UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.59B |
| 2 |
AGN
Allergan plc
AGN
|
+$763M |
| 3 |
Boeing
BA
|
+$639M |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$542M |
| 5 |
Apple
AAPL
|
+$402M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$377M |
| 2 |
Ecolab
ECL
|
+$332M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$315M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$306M |
| 5 |
CELG
Celgene Corp
CELG
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.74% |
| 2 | Financials | 7.41% |
| 3 | Healthcare | 6.49% |
| 4 | Consumer Discretionary | 5.87% |
| 5 | Industrials | 5.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPHS
4901
DELISTED
Innophos Holdings, Inc.
IPHS
| $201K | ﹤0.01% |
6,933
+6,248
| +912% | +$187K |
|
4902
Digimarc Corp
DMRC
$171M
| $200K | ﹤0.01% |
4,516
+221
| +5% | +$10.1K |
|
4903
Select Water Solutions
WTTR
$2.57B
| $200K | ﹤0.01% |
17,213
+17,200
| +132,308% | +$200K |
|
|
VIVO
4904
DELISTED
Meridian Bioscience Inc
VIVO
| $200K | ﹤0.01% |
16,838
+9,253
| +122% | +$111K |
|
4905
Ameris Bancorp
ABCB
$5.92B
| $199K | ﹤0.01% |
5,066
-22
| -0.4% | -$803 |
|
4906
AtriCure
ATRC
$2.01B
| $199K | ﹤0.01% |
6,644
+6,412
| +2,764% | +$187K |
|
4907
Nelnet
NNI
$4.85B
| $199K | ﹤0.01% |
3,364
+1,805
| +116% | +$106K |
|
|
MTEM
4908
DELISTED
Molecular Templates, Inc.
MTEM
| $199K | ﹤0.01% |
1,590
+1,581
| +17,567% | +$172K |
|
|
BRG
4909
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $199K | ﹤0.01% |
16,853
-29,092
| -63% | -$330K |
|
|
DBVT
4910
DBV Technologies
DBVT
$813M
| $198K | ﹤0.01% |
2,413
-431
| -15% | -$38.5K |
|
4911
MBIA
MBI
$269M
| $198K | ﹤0.01% |
21,316
+14,257
| +202% | +$133K |
|
4912
Grupo Aeroportuario del Sureste
ASR
$8.33B
| $197K | ﹤0.01% |
1,215
-380
| -24% | -$62.1K |
|
4913
Matrix Service
MTRX
$330M
| $197K | ﹤0.01% |
9,705
+8,523
| +721% | +$168K |
|
4914
Transmedics
TMDX
$2.78B
| $197K | ﹤0.01% |
+6,796
| New | +$186K |
|
|
ACH
4915
Accendra Health
ACH
$224M
| $196K | ﹤0.01% |
61,130
+34,496
| +130% | +$118K |
|
|
APHA
4916
DELISTED
Aphria Inc. Common Shares
APHA
| $196K | ﹤0.01% |
27,959
+9,167
| +49% | +$69.3K |
|
4917
Chunghwa Telecom
CHT
$32.8B
| $195K | ﹤0.01% |
5,344
-1,762
| -25% | -$63.1K |
|
4918
G-III Apparel Group
GIII
$1.51B
| $195K | ﹤0.01% |
6,619
+2,158
| +48% | +$73.6K |
|
4919
Global X Guru Index ETF
GURU
$62.8M
| $195K | ﹤0.01% |
5,850
-879
| -13% | -$28.6K |
|
4920
PUT
Hess Midstream
HESM
$5.13B
| $195K | ﹤0.01% |
10,000
| – | – |
|
4921
PUT
Centene
CNC
$31.7B
| $194K | ﹤0.01% |
+3,700
| New | +$200K |
|
4922
Peapack-Gladstone Financial
PGC
$815M
| $194K | ﹤0.01% |
6,879
+2,836
| +70% | +$78.6K |
|
|
IMVP
4923
Invesco India ETF
IMVP
$114M
| $194K | ﹤0.01% |
7,668
-12,725
| -62% | -$321K |
|
|
IMGN
4924
DELISTED
Immunogen Inc
IMGN
| $194K | ﹤0.01% |
89,260
-36,990
| -29% | -$87.5K |
|
|
VRS
4925
DELISTED
Verso Corporation
VRS
| $194K | ﹤0.01% |
10,169
+10,044
| +8,035% | +$203K |
|
Similar funds
UBS Group's Q2 2019 Portfolio in Review
As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group deployed $9.95B of net new capital in Q2 2019, opening 809 new positions and adding to 3,918 existing holdings. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M trimmed.
- UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
- UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
- UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
- UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
- UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
- UBS Group opened 809 new positions and closed 626 in Q2 2019.
- UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.
Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.